Research Solutions is a software - application business based in the US. Research Solutions shares (RSSS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.08 – an increase of 10% over the previous week. Research Solutions employs 145 staff and has a trailing 12-month revenue of around $44.6 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.08 |
|---|---|
| 52-week range | $2.21 - $3.50 |
| 50-day moving average | $2.70 |
| 200-day moving average | $2.80 |
| Wall St. target price | $5.12 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.13 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.99 from 2024-11-19
| 1 week (2024-11-14) | 6.79% |
|---|---|
| 1 month (2024-10-21) | 10.74% |
| 3 months (2024-08-21) | 7.55% |
| 6 months (2024-05-21) | 7.17% |
| 1 year (2023-11-21) | 31.72% |
|---|---|
| 2 years (2022-11-21) | 37.16% |
| 3 years (2021-11-19) | 24.07% |
| 5 years (2019-11-21) | 3.2 |
Valuing Research Solutions stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Research Solutions's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Research Solutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.86. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Research Solutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Research Solutions's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $66,728.
The EBITDA is a measure of a Research Solutions's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $44.6 million |
|---|---|
| Operating margin TTM | 5.45% |
| Gross profit TTM | $14.7 million |
| Return on assets TTM | -1.51% |
| Return on equity TTM | -39.81% |
| Profit margin | -8.49% |
| Book value | $0.39 |
| Market Capitalization | $91.1 million |
TTM: trailing 12 months
We're not expecting Research Solutions to pay a dividend over the next 12 months.
Over the last 12 months, Research Solutions's shares have ranged in value from as little as $2.21 up to $3.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Research Solutions's is 0.569. This would suggest that Research Solutions's shares are less volatile than average (for this exchange).
Research Solutions, Inc. , through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute. ai and scite. ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets. The company also offers Article Galaxy, a solution that allows research organizations to load their entitlements, consisting of subscriptions, discount or token packages, and their existing library of articles. In addition, it provides Manage platform, a references solution that allows users to access the article inside the platform including setting up personal folders or team folders and allows researchers to markup and take notes on the articles in a supported browser on a desktop or tablet.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.